Phoenix, Arizona — UnitedHealth Group has issued a 2025 financial outlook that has fallen short of analysts’ expectations, leading to a notable decline in its stock value by over 3% in premarket trading. The health insurance giant attributed its cautious forecast to ongoing challenges with rising medical costs, which have particularly impacted its core insurance operations.

The company projects adjusted earnings of no less than $16 per share and revenue ranging from $445.5 billion to $448 billion for 2025. This contrasts sharply with Wall Street’s consensus expectations of $20.91 per share in adjusted profit and nearly $449.16 billion in total revenue, highlighting a significant disconnect between the company’s forecasts and market anticipation.

In May, UnitedHealth’s stock experienced a steep drop after the abrupt announcement of former CEO Andrew Witty’s departure and the suspension of its 2025 guidance, all due to escalating medical expenses. This fresh report compounds the setbacks faced by the company, which is home to UnitedHealthcare, the largest health insurer in the U.S. and frequently regarded as a barometer for the industry.

Tim Noel, the current CEO of UnitedHealthcare, expressed optimism despite the apparent hurdles. He emphasized the company’s commitment to addressing current challenges while ensuring access to affordable healthcare for its customers.

The company also indicated that its medical care ratio for 2025—a critical measure comparing medical expenses to premiums—will likely be between 89% and 89.5%. A lower ratio generally favors profitability, suggesting that premiums are outpacing payouts in benefits. However, in the second quarter, this ratio grew to 89.4%, up from 85.1% a year earlier, driven primarily by rising healthcare costs.

UnitedHealth’s financial results underscore a troubling trend for the health insurance sector, particularly within Medicare Advantage plans. As more seniors seek essential procedures that were postponed during the COVID-19 pandemic, such as joint replacements, insurers like UnitedHealthcare are grappling with increased expenses that may persist throughout the industry.

In the second quarter, UnitedHealth reported earnings per share of $4.08, missing the projected $4.48, while revenue of $111.62 billion narrowly exceeded expectations of $111.52 billion. The results follow the company’s compliance with investigations by the Department of Justice regarding its Medicare billing practices, raising further scrutiny amid a challenging year.

The report also marks a pivotal moment for Stephen Hemsley, the new CEO, who is charged with restoring stakeholder confidence as UnitedHealth navigates these tumultuous waters. The company’s stock has plunged more than 44% this year, with much of the decline attributed to the DOJ investigations and its earlier suspended outlook.

The previous year has not been uneventful for UnitedHealth, which has faced a series of public relations crises, including the tragic murder of former CEO Brian Thompson and a major cyberattack impacting millions of users. As the company strives to overcome these challenges, the financial outlook and recent earnings report will be closely watched by investors and analysts alike.